•  
  •  
  •  
  •  

2026-07-21 15:51:28

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • TVS Motor Company Q1 FY27 Consolidated Net Profit Jumps 64.5% to ₹1,057.6 Crore as Revenue Crosses ₹16,200 Crore
  • Adani Energy Solutions Delivers Strong Performance in Q1 FY27 as Net Profit More Than Doubles to ₹1,236.56 Crore
  • Aditya Birla Sun Life AMC Reports 11.7% YoY Net Profit Growth to ₹309.5 Crore in Q1 FY27
  • E2E Networks Reports Stellar Q1 FY27 Results with Revenue Surging 334% YoY to ₹156.76 Crore
  • Kirloskar Pneumatic Q1 FY27 Net Profit Rises 31% to ₹33.2 Crore; CRISIL Upgrades Credit Rating to AA

Keywords Selected:  MA

Research

  • Croma's Unboxed 2022 decodes key consumer shopping trends!
  • Anand Rathi Report: India Pharma - Healthy growth in Dec'22; volumes slow down
  • New global research from Mastercard reveals Indian consumers' payment preferences
  • Expanded distillery capabilities and better realisations will increase integrated sugar mills' performance this fiscal: ICRA
  • Quant Thematic - Three factor model for stocks filtration
  • Aurobindo Pharma - Entry into India - a little too late?
  • Natco Pharma - Natco and Teva launch Revlimid in the US - ICICI Securities

Market Commentary

  • Nifty slipped below its 100-DMA amid broad-based selling led by Technologies names - Swastika Investmart Ltd

Stock Report

  • Ashiana Housing Ltd to convert units of 'Ashiana Oma' Project at Jaipur, Rajasthan
  • Alembic Pharmaceuticals Limited's Partner NATCO Pharma Limited receives USFDA Tentative Approval for Olaparib Tablets, 100 mg and 150 mg
  • NATCO receives Tentative Approval for Olaparib Tablets from the U.S. FDA
  • NATCO Pharma Ltd completes acquisition of additional 13.25% stake in Adcock Ingram Holdings Proprietary Ltd
  • OneSource Specialty Pharma and Formycon AG announce Strategic Manufacturing Partnership for Biosimilars
  • L&T Vyoma and Fortanix Partner to Deliver Confidential Computing with NVIDIA Technology
  • NATCO Pharma Ltd gets approval from its Board of Directors for increasing its stake in Adcock Ingram Holdings Proprietary Ltd to 49%
  • Marksans Pharma Ltd to acquire ABCnow GmbH
  • JSW Steel Begins Work on Rayalaseema Steel Project in Andhra Pradesh
  • Completion of US-FDA Inspection at Sterile Product Division facility at Bengaluru
  • Ajanta Pharma Ltd receives EIR from USFDA for Paithan facility
  • Aurobindo Pharma USA Inc completes acquisition of Lannett Company, Inc
  • Completion of US FDA Inspection at Auroactive Pharma Pvt Ltd
  • Honasa Consumer Ltd Enters Nutraceuticals with majority stake acquisition in Fluence Pharma
  • Aurobindo Pharma USA Receives FTC Approval to Acquire Lannett Company
  • Completion of US FDA Pre-Approval Inspection at Eugia Steriles Private Limited
  • Classification of US FDA Inspection at Unit-III of Eugia Pharma Specialities Ltd, Pashamylaram as OAI
  • Lemon Tree Hotels signs Keys Prima by Lemon Tree Hotels, Jaipur
  • Aurobindo Pharma receives final US FDA approval for Tofacitinib Tablets, 5 mg and 10 mg
  • Aurobindo Pharma Inaugurates TheraNym - Pioneering India's Large-Scale Biologics Contract Manufacturing Facility
  • Shelter Pharma Ltd receives GMP certificate
  • NATCO and Lupin receive approval from U.S. FDA for Eribulin Mesylate Injection
  • Bliss GVS Pharma Ltd gets confirmation of WHO-GMP Compliance of Manufacturing Facility
  • Shelter Pharma Ltd receives renewal of manufacturing licence

Industry News

  • Aviva India launches Aviva Nivesh Bima

Latest Post

  • TVS Motor Company Q1 FY27 Consolidated Net Profit Jumps 64.5% to ₹1,057.6 Crore as Revenue Crosses ₹16,200 Crore
  • Adani Energy Solutions Delivers Strong Performance in Q1 FY27 as Net Profit More Than Doubles to ₹1,236.56 Crore
  • Aditya Birla Sun Life AMC Reports 11.7% YoY Net Profit Growth to ₹309.5 Crore in Q1 FY27
  • E2E Networks Reports Stellar Q1 FY27 Results with Revenue Surging 334% YoY to ₹156.76 Crore
  • Kirloskar Pneumatic Q1 FY27 Net Profit Rises 31% to ₹33.2 Crore; CRISIL Upgrades Credit Rating to AA


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025